
Orthofix Medical Inc. – NASDAQ:OFIX
Orthofix Medical stock price today
Orthofix Medical stock price monthly change
Orthofix Medical stock price quarterly change
Orthofix Medical stock price yearly change
Orthofix Medical key metrics
Market Cap | 661.10M |
Enterprise value | 329.78M |
P/E | -17.95 |
EV/Sales | 0.71 |
EV/EBITDA | 21.06 |
Price/Sales | 0.77 |
Price/Book | 1.06 |
PEG ratio | -0.36 |
EPS | -3.38 |
Revenue | 760.04M |
EBITDA | -64.44M |
Income | -126.47M |
Revenue Q/Q | 7.65% |
Revenue Y/Y | 43.54% |
Profit margin | -4.29% |
Oper. margin | -6.27% |
Gross margin | 73.18% |
EBIT margin | -6.27% |
EBITDA margin | -8.48% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOrthofix Medical stock price history
Orthofix Medical stock forecast
Orthofix Medical financial statements
$24
Potential upside: 65.51%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 187.01M | -39.42M | -21.08% |
---|---|---|---|
Sep 2023 | 184.00M | -28.85M | -15.68% |
Dec 2023 | 200.41M | -22.17M | -11.06% |
Mar 2024 | 188.60M | -36.02M | -19.1% |
Jun 2023 | 901287000 | 261.30M | 28.99% |
---|---|---|---|
Sep 2023 | 905652000 | 290.16M | 32.04% |
Dec 2023 | 925315000 | 326.58M | 35.29% |
Mar 2024 | 906050000 | 335.73M | 37.05% |
Jun 2023 | -5.51M | -12.81M | 5.80M |
---|---|---|---|
Sep 2023 | 477K | -22.34M | 18.25M |
Dec 2023 | -6.19M | -14.75M | 25.28M |
Mar 2024 | -18.59M | -10.86M | 21.45M |
Orthofix Medical alternative data
Aug 2023 | 1,092 |
---|---|
Sep 2023 | 1,092 |
Oct 2023 | 1,092 |
Nov 2023 | 1,092 |
Dec 2023 | 1,092 |
Jan 2024 | 1,092 |
Feb 2024 | 1,092 |
Mar 2024 | 1,634 |
Apr 2024 | 1,634 |
May 2024 | 1,634 |
Jun 2024 | 1,634 |
Jul 2024 | 1,634 |
Orthofix Medical other data
Period | Buy | Sel |
---|---|---|
Dec 2024 | 0 | 26 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | GILLESPIE GEOFFREY C officer: CAO | Common Stock | 26 | $17.84 | $464 | ||
Option | KENNY KEVIN J. officer: Presiden.. | Common Stock | 5,959 | N/A | N/A | ||
Option | KENNY KEVIN J. officer: Presiden.. | Performance Share Units | 5,959 | N/A | N/A | ||
Purchase | HINRICHS JAMES F. director | Common Stock | 7,500 | $13.47 | $101,025 | ||
Sale | KENNY KEVIN J. officer: Presiden.. | Common Stock | 3,876 | $19 | $73,644 | ||
Sale | KENNY KEVIN J. officer: Presiden.. | Common Stock | 4,367 | $19 | $82,973 | ||
Sale | MANIAR SHWETA director | Common Stock | 4,262 | $17.75 | $75,651 | ||
Purchase | PAOLUCCI MICHAEL E director | Common Stock | 2,000 | $31.15 | $62,300 | ||
Purchase | DOUG RICE officer: CFO | Common Stock | 1,400 | $30.05 | $42,070 | ||
Purchase | BURZIK CATHERINE M director | Common Stock | 1,660 | $30.27 | $50,248 |
Quarter | Transcript |
---|---|
Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 5 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 8 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Jon C. Serbousek (1961) Pres, Chief Executive Officer & Director | $1,570,000 |
Mr. Kevin J. Kenny (1965) Pres of Global Spine Bus. | $882,140 |
Mr. Douglas C. Rice (1966) Chief Financial Officer & Chief Accounting Officer | $764,470 |
Ms. Kimberley A. Elting (1965) Chief Legal & Devel. Officer | $761,610 |
Mr. Paul W. Gonsalves (1966) Pres of Global Orthofix Orthopedics | $309,650 |
-
What's the price of Orthofix Medical stock today?
One share of Orthofix Medical stock can currently be purchased for approximately $14.5.
-
When is Orthofix Medical's next earnings date?
Unfortunately, Orthofix Medical's (OFIX) next earnings date is currently unknown.
-
Does Orthofix Medical pay dividends?
No, Orthofix Medical does not pay dividends.
-
How much money does Orthofix Medical make?
Orthofix Medical has a market capitalization of 661.10M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 62.06% to 746.64M US dollars.
-
What is Orthofix Medical's stock symbol?
Orthofix Medical Inc. is traded on the NASDAQ under the ticker symbol "OFIX".
-
What is Orthofix Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Orthofix Medical?
Shares of Orthofix Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Orthofix Medical's key executives?
Orthofix Medical's management team includes the following people:
- Mr. Jon C. Serbousek Pres, Chief Executive Officer & Director(age: 64, pay: $1,570,000)
- Mr. Kevin J. Kenny Pres of Global Spine Bus.(age: 60, pay: $882,140)
- Mr. Douglas C. Rice Chief Financial Officer & Chief Accounting Officer(age: 59, pay: $764,470)
- Ms. Kimberley A. Elting Chief Legal & Devel. Officer(age: 60, pay: $761,610)
- Mr. Paul W. Gonsalves Pres of Global Orthofix Orthopedics(age: 59, pay: $309,650)
-
How many employees does Orthofix Medical have?
As Jul 2024, Orthofix Medical employs 1,634 workers.
-
When Orthofix Medical went public?
Orthofix Medical Inc. is publicly traded company for more then 33 years since IPO on 24 Apr 1992.
-
What is Orthofix Medical's official website?
The official website for Orthofix Medical is orthofix.com.
-
Where are Orthofix Medical's headquarters?
Orthofix Medical is headquartered at 3451 Plano Parkway, Lewisville, TX.
-
How can i contact Orthofix Medical?
Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville, TX and company can be reached via phone at 214 937 2000.
-
What is Orthofix Medical stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Orthofix Medical in the last 12 months, the avarage price target is $24. The average price target represents a 65.51% change from the last price of $14.5.
Orthofix Medical company profile:

Orthofix Medical Inc.
orthofix.comNASDAQ
1,634
Medical - Devices
Healthcare
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Lewisville, TX 75056
CIK: 0000884624
ISIN: US68752M1080
CUSIP: 68752M108